Wikidata

(Q64660470)

English

A Study of Tocilizumab as Monotherapy and in Combination With Methotrexate Versus Methotrexate in Patients With Early Moderate to Severe Rheumatoid Arthritis

clinical trial

In more languages
default values for all languages
No label defined

No description defined

Statements

title
A Multi-center, Randomized, Double-blind, Parallel Group Study of the Safety, Disease Remission and Prevention of Structural Joint Damage During Treatment With Tocilizumab (TCZ), as a Monotherapy and in Combination With Methotrexate (MTX), Versus Methotrexate in Patients With Early, Moderate to Severe Rheumatoid Arthritis (English)
0 references
sponsor
Hoffmann-La Roche
0 references
country
Argentina
0 references
Australia
0 references
Austria
0 references
Brazil
0 references
Canada
0 references
Colombia
0 references
Denmark
0 references
Finland
0 references
France
0 references
Germany
0 references
Greece
0 references
Guatemala
0 references
Hungary
0 references
Republic of Ireland
0 references
Israel
0 references
Italy
0 references
Mexico
0 references
New Zealand
0 references
Panama
0 references
Peru
0 references
Philippines
0 references
Poland
0 references
Portugal
0 references
Singapore
0 references
South Africa
0 references
Spain
0 references
Sweden
0 references
Thailand
0 references
Turkey
0 references
United Kingdom
0 references
start time
31 October 2009
0 references
end time
31 May 2012
0 references
number of participants
1,162
0 references
minimum age
18 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q64660470&oldid=2208512392"